These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 6717508)
1. Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. Taylor KM; Margolese RG; Soskolne CL N Engl J Med; 1984 May; 310(21):1363-7. PubMed ID: 6717508 [TBL] [Abstract][Full Text] [Related]
2. The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06. Christian MC; McCabe MS; Korn EL; Abrams JS; Kaplan RS; Friedman MA N Engl J Med; 1995 Nov; 333(22):1469-74. PubMed ID: 7477148 [TBL] [Abstract][Full Text] [Related]
3. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. Deutsch M; Land SR; Begovic M; Wieand HS; Wolmark N; Fisher B Cancer; 2003 Oct; 98(7):1362-8. PubMed ID: 14508821 [TBL] [Abstract][Full Text] [Related]
4. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. Fisher B; Bauer M; Margolese R; Poisson R; Pilch Y; Redmond C; Fisher E; Wolmark N; Deutsch M; Montague E N Engl J Med; 1985 Mar; 312(11):665-73. PubMed ID: 3883167 [TBL] [Abstract][Full Text] [Related]
5. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. Fisher B; Anderson S; Redmond CK; Wolmark N; Wickerham DL; Cronin WM N Engl J Med; 1995 Nov; 333(22):1456-61. PubMed ID: 7477145 [TBL] [Abstract][Full Text] [Related]
7. The impact of the physician on the accrual to randomized clinical trials in patients with primary operable breast cancer. Kaas R; Hart AA; Rutgers EJ Breast; 2005 Aug; 14(4):310-6. PubMed ID: 16085238 [TBL] [Abstract][Full Text] [Related]
8. Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. Yen TW; Hunt KK; Mirza NQ; Thomas ES; Singletary SE; Babiera GV; Meric-Bernstam F; Buchholz TA; Feig BW; Ross MI; Ames FC; Theriault RL; Kuerer HM Cancer; 2004 Mar; 100(5):942-9. PubMed ID: 14983489 [TBL] [Abstract][Full Text] [Related]
9. Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy. Fisher B; Slack N; Katrych D; Wolmark N Surg Gynecol Obstet; 1975 Apr; 140(4):528-34. PubMed ID: 805475 [TBL] [Abstract][Full Text] [Related]
10. The incidence of arm edema in women with breast cancer randomized on the National Surgical Adjuvant Breast and Bowel Project study B-04 to radical mastectomy versus total mastectomy and radiotherapy versus total mastectomy alone. Deutsch M; Land S; Begovic M; Sharif S Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1020-4. PubMed ID: 18029105 [TBL] [Abstract][Full Text] [Related]
11. Overview of randomized trials comparing radical mastectomy without radiotherapy against simple mastectomy with radiotherapy in breast cancer. Cuzick J; Stewart H; Peto R; Fisher B; Kaae S; Johansen H; Lythgoe JP; Prescott RJ Cancer Treat Rep; 1987 Jan; 71(1):7-14. PubMed ID: 3539330 [TBL] [Abstract][Full Text] [Related]
12. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cuzick J; Stewart H; Peto R; Baum M; Fisher B; Host H; Lythgoe JP; Ribeiro G; Scheurlen H; Wallgren A Cancer Treat Rep; 1987 Jan; 71(1):15-29. PubMed ID: 2856861 [TBL] [Abstract][Full Text] [Related]
13. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials. Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044 [TBL] [Abstract][Full Text] [Related]
14. Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents. Glass A; Wieand HS; Fisher B; Redmond C; Lerner H; Wolter J; Shibata H; Plotkin D; Foster R; Margolese R; Wolmark N Cancer Treat Rep; 1981; 65(5-6):363-76. PubMed ID: 7016322 [TBL] [Abstract][Full Text] [Related]
15. Ethical communication in clinical trials. Issues faced by data managers in obtaining informed consent. Loh WY; Butow PN; Brown RF; Boyle F Cancer; 2002 Dec; 95(11):2414-21. PubMed ID: 12436450 [TBL] [Abstract][Full Text] [Related]
16. The doctor's dilemma: physician participation in randomized clinical trials. Taylor KM Cancer Treat Rep; 1985 Oct; 69(10):1095-100. PubMed ID: 4042089 [No Abstract] [Full Text] [Related]
17. Adjuvant therapy for breast cancer. NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506 [TBL] [Abstract][Full Text] [Related]
19. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. Fisher B; Redmond C; Fisher ER; Bauer M; Wolmark N; Wickerham DL; Deutsch M; Montague E; Margolese R; Foster R N Engl J Med; 1985 Mar; 312(11):674-81. PubMed ID: 3883168 [TBL] [Abstract][Full Text] [Related]
20. Temporal trends in breast cancer surgery in Ontario: can one randomized trial make a difference? Iscoe NA; Naylor CD; Williams JI; DeBoer G; Morgan MW; Fehringer G; Holowaty E CMAJ; 1994 Apr; 150(7):1109-15. PubMed ID: 8137191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]